NewsCase
.com
Financial Intelligence
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
Menu
Market Analysis
Defense & Aerospace
AI & Tech
Banking & Finance
Crypto
European Stocks
Search NewsCase
CureVac
CureVac’s Final Chapter: A Forced Exit from the Nasdaq
angelina
-
December 24, 2025
A New Chapter Begins as BioNTech Finalizes CureVac Acquisition
December 22, 2025
CureVac’s Final Chapter: BioNTech Completes Acquisition and Delisting Process
December 20, 2025
CureVac’s Stock Market Exit Approaches Following BioNTech Acquisition
kashif hafeez
-
December 19, 2025
CureVac Shareholders Face Final Decision in BioNTech Takeover
Brett Shapiro
-
December 12, 2025
A Final Decision Deadline for CureVac Shareholders
December 11, 2025
CureVac Shareholders Face Final Decision in BioNTech Takeover
kashif hafeez
-
December 4, 2025
CureVac Shareholders Face Critical Deadline in BioNTech Merger
Brett Shapiro
-
November 29, 2025
CureVac Shareholders Face Critical Deadline in BioNTech Takeover
November 27, 2025
CureVac Shareholders Face Final Decision on BioNTech Takeover
angelina
-
November 21, 2025
CureVac’s Fate Hangs in Balance as Shareholders Prepare for Crucial Vote
kashif hafeez
-
November 16, 2025
CureVac Investors Face Critical Takeover Decision
Brett Shapiro
-
November 15, 2025
CureVac Investors Face Crucial Vote on BioNTech Acquisition
Brett Shapiro
-
November 12, 2025